Part of the evaluation of breast cancer will involve special blood tests that determine whether or not the tumor is estrogen-receptor sensitive. Estrogen receptor sensitive tumors are the type that grows when exposed to the female sex hormone estrogen. They are more common in postmenopausal women. Hormone receptor status is important because it is an important factor in determining the best drug treatment.